[1. PİSETSKY DS, LİPSKY PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020 Oct;16(10):565–79.10.1038/s41584-020-0480-7]Search in Google Scholar
[2. NOSAL RS, SUPERVİLLE SS, VARACALLO M. Biochemistry, Antinuclear Antibodies (ANA). In Treasure Island (FL); 2021.]Search in Google Scholar
[3. CHAN EKL, DAMOİSEAUX J, CARBALLO OG, CONRAD K, DE MELO CRUVİNEL W, FRANCESCANTONİO PLC, et al. Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015. Front Immunol. 2015;6:412.10.3389/fimmu.2015.00412]Search in Google Scholar
[4. GANAPATHY V, CASİANO CA. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis and rheumatism. United States; 2004;50:684–8.]Search in Google Scholar
[5. OCHS RL, STEİN TWJ, PEEBLES CL, GİTTES RF, TAN EM. Autoantibodies in interstitial cystitis. J Urol. 1994;151(3):587–92.10.1016/S0022-5347(17)35023-1]Search in Google Scholar
[6. BİZZARO N, TONUTTİ E, VİSENTİNİ D, ALESSİO MG, PLATZGUMMER S, MOROZZİ G, et al. Antibodies to the lens and cornea in anti-DFS70-positive subjects. Ann N Y Acad Sci. 2007;1107:174–83.10.1196/annals.1381.019]Search in Google Scholar
[7. DANİELS T, ZHANG J, GUTİERREZ I, ELLİOT ML, YAMADA B, HEEB MJ, et al. Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate. 2005;62(1):14–26.10.1002/pros.20112]Search in Google Scholar
[8. OCHS RL, MURO Y, Sİ Y, GE H, CHAN EK, TAN EM. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol. 2000;105(6 Pt 1):1211–20.10.1067/mai.2000.107039]Search in Google Scholar
[9. AYAKİ M, OHOGURO N, AZUMA N, MAJİMA Y, YATA K, IBARAKİ N, et al. Detection of cytotoxic anti-LEDGF autoantibodies in atopic dermatitis. Autoimmunity. 2002;35(5):319–27.10.1080/0891693021000003198]Search in Google Scholar
[10. OKAMOTO M, OGAWA Y, WATANABE A, SUGİURA K, SHİMOMURA Y, AOKİ N, et al. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun. 2004;23(3):257–66.10.1016/j.jaut.2004.07.004]Search in Google Scholar
[11. YAMADA K, SENJU S, SHİNOHARA T, NAKATSURA T, MURATA Y, ISHİHARA M, et al. Humoral immune response directed against LEDGF in patients with VKH. Immunol Lett. 2001;78(3):161–8.10.1016/S0165-2478(01)00243-7]Search in Google Scholar
[12. YUMUK Z, DEMİR M. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing. J Immunol Methods. 2020;480:112754.10.1016/j.jim.2020.11275432057435]Search in Google Scholar
[13. LA JEON Y, KANG SY, LEE W-I, KİM MH. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies. Ann Clin Lab Sci. 2019;49(4):496–502.]Search in Google Scholar
[14. PASHNİNA IA, KRİVOLAPOVA IM, FEDOTKİNA T V, RYABKOVA VA, CHERESHNEVA M V, CHURİLOV LP, et al. Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease. Antibodies (Basel, Switzerland). 2021;10(1).10.3390/antib10010009800615333668697]Search in Google Scholar
[15. SEELİG CA, BAUER O, SEELİG H-P. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD). Clin Lab. 2016;62(4):499–517.10.7754/Clin.Lab.2015.150905]Search in Google Scholar
[16. MULHEARN B, TANSLEY SL, MCHUGH NJ. Autoantibodies in connective tissue disease. Best Pract Res Clin Rheumatol. 2020;34(1):101462.10.1016/j.berh.2019.10146231848055]Search in Google Scholar
[17. ALMEİDA GONZÁLEZ D, ROCES VARELA A, MARCELİNO RODRÍGUEZ I, GONZÁLEZ VERA A, DELGADO SÁNCHEZ M, AZNAR ESQUİVEL A, et al. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection. J Immunol Methods. 2015;427:30–5.10.1016/j.jim.2015.09.00326407840]Search in Google Scholar
[18. MAHLER M, PARKER T, PEEBLES CL, ANDRADE LE, SWART A, CARBONE Y, et al. Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases. J Rheumatol 2012;39(11):210410.3899/jrheum.12059822942262]Search in Google Scholar
[19. PEPMUELLER PH. Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology. Mo Med. 2016;113(2):136–40.]Search in Google Scholar
[20. INFANTİNO M, SHOVMAN O, PÉREZ D, MANFREDİ M, GROSSİ V, BENUCCİ M, et al. Anti-DFS70 autoantibodies in undifferentiated connective tissue diseases subjects: what’s on the horizon? Rheumatology (Oxford). 2018;57(7):1293–8.10.1093/rheumatology/key01229618128]Search in Google Scholar
[21. ROMERO-ÁLVAREZ V, ACERO-MOLİNA DA, BELTRÁN-OSTOS A, BELLO-GUALTEROS JM, ROMERO-SÁNCHEZ C. Frequency of ANA/DFS70 in Relatives of Patients with Rheumatoid Arthritis Compared to Patients with Rheumatoid Arthritis and a Healthy Population, and its Association with Health Status. Reumatol Clin. 2021;17(2):67–73.10.1016/j.reuma.2019.02.00331104879]Search in Google Scholar
[22. HAYASHİ N, UTO K, IMANİSHİ A, SUGİYAMA D, MORİNOBU A, SAEGUSA J. Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan. Medicine (Baltimore). 2021;100(9):e24556.10.1097/MD.0000000000024556793920033655922]Search in Google Scholar
[23. MURO Y, SUGİURA K, MORİTA Y, TOMİTA Y. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus. 2008;17(3):171–6.10.1177/096120330708631118372356]Search in Google Scholar
[24. WATANABE A, KODERA M, SUGİURA K, USUDA T, TAN EM, TAKASAKİ Y, et al. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum. 2004;50(3):892–900.10.1002/art.2009615022332]Search in Google Scholar
[25. CHOİ MY, CLARKE AE, ST PİERRE Y, HANLY JG, UROWİTZ MB, ROMERO-DİAZ J, et al. The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients. Lupus. 2017;26(10):1051–9.10.1177/096120331769243728420054]Search in Google Scholar
[26. KANG SY, LEE WI, KİM MH, LA JEON Y. Clinical use of anti-DFS70 autoantibodies. Rheumatol Int. 2019;39(8):1423–9.10.1007/s00296-019-04299-430972541]Search in Google Scholar